Introduction
Cannabis stocks moved sharply higher this week after U.S. President Donald Trump publicly endorsed the use of cannabidiol (CBD) for senior healthcare with the reposting of a video that highlighted CBD's potential to “revolutionize senior healthcare” by:
- slowing the progression of diseases,
- providing alternatives to prescription drugs,
- reducing pain and stress,
- improving sleep, and
- helping deal with health issues, including cancer symptoms and Alzheimer's.
The three-minute video also includes a Fox News segment outlining the financial advantages of legalizing marijuana for medical purposes maintaining that it would lead to cost savings of “$64 billion a year if cannabis is fully integrated into the healthcare system”.
American Cannabis MSO Stocks Portfolio
That is all the investors/speculators in cannabis MSOs needed to drive the prices of the 6 largest such stocks in our American Cannabis MSO Stocks Portfolio skyward week ending October 3rd. Below are the performances of its 6 constituents, in descending order, for the week, and YTD, and a chart showing how the Portfolio has performed over various time periods:
- Cresco (CRLBF): UP 35.0% week-ending October 3rd; UP 69.5% YTD
- Verano (VRNOF): UP 29.8% week-ending October 3rd; UP 25.4% YTD
- Curaleaf (CURLF): UP 28.9% week-ending October 3rd; UP 109.0% YTD
- Trulieve (TCNNF): UP 18.7% week-ending October 3rd; UP 79.5% YTD
- Green Thumb (GTBIF): UP 16.9% week-ending October 3rd; UP 10.7% YTD
- TerrAscend (TSNDF): UP 15.3% week-ending October 3rd; UP 38.3% YTD
Summary
The above stocks were UP 20.6%, on average, week-ending October 3rd and are now UP 44.1% YTD.
A Comparison Chart Of The Performance Of The 6 Constituents YTD

Source: StockCharts.com
A Chart Of The Performance Of The Portfolio YTD

The above portfolio chart has been generated using the tools provided by PortfoliosLab.com and easy step-by-step instructions are available here to help you create a chart of your own portfolio or that of a client. It's easy, fast and free.


.webp)
Comments
Log in or sign up to join the conversation.